Chikungunya

Fully automatable detection of acute infection

The Chikungunya virus has recently been garnering attention in the Pacific region, as the number of cases slowly grows.  Transmitted by Aedes aegypti and Aedes albopictus mosquitoes, Chikungunya fever is typically diagnosed in people who have recently travelled overseas, although the Aedes aegypti mosquito is found in some parts of Queensland.  The virus has been identified in nearly 40 countries worldwide, and has been found in the Pacific region since 2011.  

Symptoms of Chikungunya infection include fever, polyarthralgia, conjunctivitis, nausea, and maculopapular rash.  Several clinical signs are shared with dengue, which can lead to misdiagnosis.

Euroimmun offer Anti-Chikungunya Virus ELISA tests for IgG and IgM. In-vitro determination of antibodies against Chikungunya virus may be found in human serum or plasma for diagnosis of Chikungunya fever and differential diagnosis of haemorrhagic fever.

The ELISA exhibits excellent linearity, sensitivity, and reproducibility. No cross reactivity in patients with other infectious diseases was found for either test during Euroimmun's thorough scientific testing.